My Account
About Us
Contact us
الواجهة العربية
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »



You must sign in to use this servcie

Feedback - Please use the form below to send your query or comment

You must sign in to use this servcie




Treatment of infections of lower respiratory tract including pneumonia, urinary tract, skin and skin structures, bone and joints; treatment of bacteremia/septicemia, CNS infections, intra-abdominal infections including peritonitis, gynecological infections including pelvic inflammatory disease, endometritis and pelvic cellulitis caused by susceptible strains of specific microorganisms; perioperative prophylaxis.


Hypersensitivity to cephalosporins.

Adverse reactions:

GI Colitis, diarrhea, nausea, vomiting (at least 1%); pseudomembranous colitis symptoms can occur during or after treatment. Hypersensitivity Rash, pruritus, fever, eosinophilia, urticaria, anaphylaxis (at least 1%). Local Injection-site inflammation with IV administration; pain and induration, tenderness after IM administration (at least 1%).


Aminoglycosides Increased risk of nephrotoxicity. Incompatibility Do not add aminoglycosides to cefotaxime solutions because inactivation of both drugs may result; administer at separate sites if concurrent therapy is indicated. Laboratory Test Interactions False-positive direct Coombs test results in certain patients (eg, those with azotemia).


Monitor Review results of culture and sensitivity testing as appropriate. Ensure that cefotaxime is discontinued and another antimicrobial agent is started if sensitivity tests indicate that the organism is resistant to cefotaxime. Pregnancy Category B . Lactation Excreted in breast milk. Elderly Because elderly patients are more likely to have decreased renal function, use care in dose selection and consider monitoring renal function. Hypersensitivity Reactions range from mild to life-threatening. Administer drug with caution to penicillin-sensitive patients because of possible cross-reactivity. Renal Function Use with caution. Reduce dose when Ccr is less than 20 mL/min. Superinfection May result in bacterial or fungal overgrowth of nonsusceptible microorganisms. GI disease Use with caution, especially in patients with history of colitis. Granulocytopenia Granulocytopenia, and more rarely, agranulocytosis, may develop during treatment with cefotaxime, particularly if given over long periods. Monitor CBC during course of treatment lasting longer than 10 days. Local irritation May be locally irritating to tissues in the event of extravasation. Regularly monitor infusion sites and change when appropriate. Pseudomembranous colitis Consider in patients in whom diarrhea develops.


Injectable - IM/IV

Dosage and Administration

You must sign in to use this servcie

Technical Description

You must sign in to use this servcie

Forgot your password

sign up

Consultants Corner

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr. Talal Sabouni


Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Which of the following you are mostly interested in?

Cancer Research
Mental Health
Heart Disease & Diabetes
Sexual Health
Obesity and Healthy Diets
Mother & Child Health

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details